FS KKR Capital (FSK) allegedly reassured investors that its portfolio credit profile was improving, non-accrual issues were being addressed, and distributions remained attractive. But the complaint alleges those assurances masked deeper portfolio and valuation problems.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
A federal securities lawsuit filed on May 4, 2026, in the Eastern District of Pennsylvania alleges that FS KKR Capital Corp. misled investors about the health of its loan portfolio and the sustainability of its dividend, while the company’s stock lost significant value across two separate disclosure events.
The lawsuit covers a class period from May 8, 2024, through February 25, 2026, and names the company, along with its Chief Executive Officer and Chief Financial Officer, as defendants. The complaint alleges that investors suffered losses when the company disclosed deteriorating portfolio conditions on August 6, 2025, sending shares down approximately 8.2%, and again on February 25, 2026, when shares fell another 15.24%. Both drops are alleged to reflect corrective disclosures about portfolio problems the company had previously downplayed.
Investors who purchased FS KKR Capital stock during the class period can check whether they may be eligible to participate.
About FS KKR Capital Corp. and Its Business Model
FS KKR Capital Corp. is a Business Development Company, or BDC, incorporated in Maryland with principal offices in Philadelphia, Pennsylvania. Its common stock trades on the New York Stock Exchange under the ticker symbol FSK. The company operates by extending loans, referred to as debt investments, to private companies, with interest income from those loans serving as its primary revenue source.
As a regulated BDC, the company is subject to statutory limits on the amount of debt it may carry relative to its net asset value, or NAV. Investors in BDCs watch NAV closely because declines in portfolio valuations reduce NAV, which in turn can pressure a company to sell assets to remain compliant with asset coverage requirements. The complaint explains this dynamic as the central context for understanding the significance of the alleged misstatements.
What the Lawsuit Alleges Went Wrong
The complaint centers on four broad categories of alleged misrepresentation. It alleges that defendants overstated the effectiveness of the company’s restructuring efforts for nonaccrual investments, overstated the fair value of portfolio holdings, overstated the durability of its quarterly distribution strategy, and, as a result, allegedly made materially misleading positive statements about the company’s business prospects throughout the class period.
The complaint alleges that for five consecutive quarters through the first quarter of 2025, management represented that the company was making meaningful progress in improving its portfolio credit profile and that legacy investment problems were being adequately addressed. The complaint contends that those representations lacked a reasonable basis, given what was later disclosed about the breadth and severity of the underlying portfolio challenges.
FSK investors can learn more about the FS KKR Capital securities lawsuit and check their eligibility.
What Management Said During the Class Period
The complaint quotes extensively from quarterly press releases attributed to Michael C. Forman, the company’s Chief Executive Officer. In May 2024, Forman stated the company had made significant progress restructuring certain non-accruing investments and expressed confidence in the company’s long-term earnings power and its ability to reward shareholders with attractive distributions. Similar language appeared in releases through early 2025.
In August 2024, Forman characterized the second quarter as another solid quarter, citing reductions in non-accrual investments and reaffirming a minimum distribution target of $2.90 per share for 2024. In February 2025, Forman described results as reflecting continued strong performance, citing portfolio stability and a well-laddered capital structure. In May 2025, he stated the company’s spillover income strategy supported the continued stability of its base and supplemental quarterly distributions.
In November 2025, following a partial disclosure in August, Forman announced a 2026 distribution strategy the company believed would yield approximately 10% on NAV, consistent with long-term BDC industry norms. The complaint alleges these statements were materially misleading given undisclosed portfolio conditions at the time they were made.
How the Alleged Truth Came to Light
The complaint identifies two alleged corrective disclosures. The first occurred on August 6, 2025, when the company reported second-quarter 2025 earnings after market close. That report revealed NAV had dropped to $21.93 per share, a decline of $1.44 or 6.2% from the prior quarter, while the total fair value of investments fell by $474 million. Earnings per share came in at negative $0.75, and non-accrual investments rose to 3.0% at fair value and 5.3% at amortized cost. On August 7, 2025, shares fell $1.66, or 8.20%, on unusually heavy trading volume.
The company attributed the deterioration to company-specific issues at four portfolio companies: Production Resource Group, 48forty, Kellermeyer Bergensons Services, and Worldwise. Management characterized these as isolated situations while assuring investors that broader portfolio and private credit market conditions remained stable. The complaint alleges this framing continued to obscure the full extent of the problems.
The second disclosure came on February 25, 2026, also after market close. The company reported that NAV had declined further to $20.89 per share, and that an additional $406 million in investment fair value had been lost. Earnings per share were negative $0.41, and non-accrual investments rose again to 3.4% at fair value and 5.5% at amortized cost. The company acknowledged specific challenges at additional companies, including Medallia and Cubic Corp., and cut its quarterly dividend from $0.70 to $0.48 per share. Management also acknowledged that approximately 50% of fourth-quarter net realized and unrealized losses were attributable to four investments: Production Resource Group, Medallia, Peraton, and Cubic Corp. On February 26, 2026, shares fell $2.03, or 15.24%, on unusually heavy trading volume.
Why This Case May Matter to FSK Shareholders
The case alleges that investors who purchased FSK shares during the class period did so at prices artificially inflated by misleading statements about portfolio quality, restructuring progress, and dividend sustainability. The complaint alleges that as corrective information emerged across two disclosure events, FSK’s share price declined sharply, causing losses for investors who allegedly relied on management’s prior representations. The complaint notes that FSK shares reached a class-period high of $24.06 on February 19, 2025, before the subsequent declines.
The significance of NAV to BDC investors is central to the allegations. Because BDC investors monitor NAV as a primary measure of portfolio health and financial stability, statements that overstate NAV or understate portfolio stress may be particularly relevant in assessing alleged investor reliance and damages. The complaint also alleges that the company’s dividend disclosures were materially misleading, which is notable given that income generation is a primary reason many retail investors hold BDC securities.
Legal Claims Asserted in the Complaint
The complaint brings claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as well as Rule 10b-5 promulgated thereunder by the SEC. The Section 10(b) and Rule 10b-5 claim is asserted against all defendants and alleges the use of devices, schemes, and materially false or misleading statements to artificially inflate the price of FS KKR Capital securities. The Section 20(a) claim is asserted against the individual defendants, Forman and Lilly, in their capacity as controlling persons of the company.
Plaintiff relies on the fraud-on-the-market doctrine to establish a presumption of reliance, asserting that FSK shares traded in an efficient market and that the alleged misstatements were incorporated into the market price. The complaint also invokes the Supreme Court’s Affiliated Ute presumption, given that the claims are substantially grounded in alleged omissions of material adverse information. Plaintiff demands a jury trial and seeks compensatory damages, costs, and attorneys’ fees on behalf of the proposed class.
FSK investors who purchased shares between May 8, 2024, and February 25, 2026, can check whether they may be eligible to participate.
About Levi & Korsinsky, LLP
Levi & Korsinsky, LLP is a nationally recognized securities litigation firm representing investors in complex shareholder actions. The firm has extensive expertise and a team of over 70 employees to serve our clients. Attorney advertising. Prior results do not guarantee similar outcomes.
Disclaimer: This article is provided for informational purposes only and does not constitute legal advice. No attorney-client relationship is created by reading this article. Past results do not guarantee similar outcomes.